- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01921725
The Clinical Application and Efficacy Verification of an Innovative Carbon Fiber Dressing
The research uses hydrophilic-based dressing (KoCarbonTM) which is developed by Medical Technology Company Limited (Bio-medical Carbon Technology; BCT) to investigate the wound healing effects of activated-carbon-fiber-based wound dressing on different types of wounds.The dressing is composed by three layers. The first layer is a material of polyethylene terephthalate (PET) weave which is great breathable; Second layer, the activated carbon fiber cloth, is as the absorption of excess tissue fluid, bacteria and contaminations. It reduces the smell of wound and restrains the development of bacteria. In addition, activated carbon has features of far-infrared and anion, which promote blood circulation, speed up metabolism and shorten the time of wound healing. The third layer is a polyethlene (PE) film, which touches the wound surface and provides the anti-adhesion effects.
The aim of this study is to investigate how the application of the dressing affects the wound healing conditions on four different types of wounds, including general traumatic wounds, elective surgery wound, diabetes foot ulcer (level 2) and chronic wounds. Due to the characteristics of great fluid absorption and far-infrared features, the hydrophilic-based dressing (KoCarbonTM) is expected to work perfectly on improving the wound repair conditions.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Taichung, Taiwan, 40447
- Division of Plastic Surgery, Department of Surgery, China Medical University Hospital
-
Yunlin County, Taiwan, 65152
- Division of Plastic Surgery, Department of Surgery, China Medical University Beigang Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Male/Female of any race aged between 20 - 85 years old
- The subject is willing and able to understand, sign and date the study Informed Consent
- The subject is able to adhere to the scheduled visits regimen
- General traumatic wounds: wound length is less than 20 cm, area less than 100 cm2, and depth less than 0.5 cm
- Elective surgery wound: wound length less than 20 cm, and apply BCT KoCarbon® Hydrophilic Wound Dressing immediately after surgery
- Diabetes foot ulcer (level 2): wound area is between 0.5 cm x 0.5 cm - 5 cm x 5 cm
- Chronic wounds: failed to heal for more than 1 month and wound area is between 0.5 cm x 0.5 cm - 10 cm x 10 cm
Exclusion Criteria:
- Male/Female of any race aged younger than 20 years old or older than 85 years old
- Allergy to activated carbon fiber
- Patients was participating in another clinical trial less than 30 days before participation in this trial
- Any systemic or local active dermatological disease that might interfere with the evaluation of the surgical site such as eczema, psoriasis, skin cancer, scleroderma, chronic urticarial
- Taking any medicine containing steroid in the last 3 months
- With history of cardiovascular diseases, diabetes mellitus, immune system-related diseases, hepatic disease, hematic diseases, renal diseases, and cancer
- Pregnancy
- Severe malnutrition
- fistula or tunnel wounds
- General traumatic wounds: already been infected, or have accepted other treatments for more than 1 week
- Elective surgery wound: already been infected, or delayed suture
- Diabetes foot ulcer (level 2): combined with necrotizing fasciitis or bone and tendon exposure
- Chronic wounds: combined with necrotizing fasciitis or bone and tendon exposure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Hydrophilic-based dressing (KoCarbonTM)
The wound is first cleansed with normal saline, and then applied with hydrophilic-based dressing (KoCarbonTM) and covered by sterile gauze.
The frequency of dressing chang is depend on the amount of exudate.
|
"BCT" Hydrophilic Wound Dressing consists of PET non-woven, activated carbon fiber (ACF) cloth and PE film.
The PET non-woven is vapor permeable to allow air exchange for the wound.
The absorbent ACF absorbs exudate, bacteria and odor to create an effective barrier.
Furthermore, far infrared ray (FIR) emitted from ACF accelerates blood circulation and metabolism to reduce healing period.
The PE film helps to minimize wound trauma at dressing changes.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The healing percentage
Time Frame: one month
|
Photograph of wounds are taken on each visit and pictures are imported to image-analyzing software for the calculation of wound area.
And the number of wound area is then transformed to the healing percentage.
Healing Percentage N =[(the initial wound area-wound area measured on Day N)/the initial wound area]x100%.
N means the number of days counting from the first day initiating this clinical trial.
|
one month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The healing rate
Time Frame: one month
|
Photograph of wounds are taken on each visit and pictures are imported to image-analyzing software for the calculation of wound area.
And the number of wound area is then transformed to the healing rate.
Healing Rate= healed area/the number of healing days (cm2/day)
|
one month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Antibiotics usage
Time Frame: one month
|
The dose and frequency of antibiotics usage of each subject during the whole trial will be recorded.
|
one month
|
Infection rate
Time Frame: one month
|
The occurrence rate of infection among all the subjects will be calculated.
|
one month
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Tzong-Shiun Li, M.D., Ph.D., Division of Plastic Surgery, Department of Surgery, China Medical University Hospital
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- DMR101-IRB2-156
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Wounds
-
Centre Hospitalier Universitaire de NīmesCompleted
-
University of WashingtonU.S. Department of Justice; Arnold Ventures; City of SeattleCompleted
-
3MWithdrawn
-
Hospital Universiti Sains MalaysiaActive, not recruiting
-
Ohio State UniversityCompleted
-
University of PittsburghThe Pittsburgh Foundation; Hillman Foundation; RK Mellon FoundationCompletedSkin Injury Due to Violence | Gunshot Wound, ContactUnited States
-
SerenaGroup, Inc.Anacapa Technologies IncCompleted
-
Medical University of South CarolinaCompletedNeedlestick InjuriesUnited States
-
Smith & Nephew, Inc.Not yet recruitingChronic Wounds | Acute WoundsCanada
-
SerenaGroup, Inc.MDM Wound Ventures, LLCCompletedChronic Wounds | Acute WoundsUnited States
Clinical Trials on hydrophilic-based dressing (KoCarbonTM)
-
Magda BayoumiCompleted
-
Damascus UniversityCompletedGingival RecessionSyrian Arab Republic
-
University of California, Los AngelesRecruitingCardiovascular Diseases | Atherosclerosis | Arterial Occlusion | HematomaUnited States
-
University of California, Los AngelesCompletedCardiovascular Diseases | Arterial Occlusion | HematomaUnited States
-
Next Science TMAdvancing the Zenith of HealthcareTerminated
-
Tangible ScienceUniversity of California, Davis; Nova Southeastern University; Illinois College...CompletedDry Eye | Dry Eye SyndromesUnited States
-
MAİDE YEŞİLYURTNecmettin Erbakan UniversityCompletedPressure Injury | Nasogastric Tube | Medical Device Site InjuryTurkey
-
Smith & Nephew, Inc.Completed
-
University of MalayaCompletedDentoalveolar AbscessMalaysia
-
OHSU Knight Cancer InstituteOregon Health and Science UniversityNot yet recruitingBreast Carcinoma | Head and Neck Carcinoma | Radiation-Induced DermatitisUnited States